
Salutem Pharmaceuticals Private Limited
Pharmaceutical company specializing in manufacturing, formulating, and trading various medicinal products.
Pharmaceutical company specializing in manufacturing, formulating, and trading various medicinal products.
Salutem Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 October 2016 (Eight years and four months 19 days old ). Its registered office is in Jammu, Jammu & Kashmir, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sahil Mahajan and Mandeep Bhamra serve as directors at the Company.
Jammu, Jammu & Kashmir, India
+91-XXXXXXXXXX
-
U24290JK2016PTC009772
009772
Private Limited Indian Non-Government Company
13 Oct 2016
30 Sep 2024
31 Mar 2024
Unlisted
Roc Jammu
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sahil Mahajan ![]() | Director | 13-Oct-2016 | Current |
Mandeep Bhamra ![]() | Director | 17-Jul-2021 | Current |
Salutem Pharmaceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 8.97% decrease. The company also saw a substantial improvement in profitability, with a 86.41% increase in profit. The company's net worth Soared by an impressive increase of 16409.67%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2018, Salutem Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Sahil Mahajan is a mutual person
Sahil Mahajan is a mutual person
Sahil Mahajan is a mutual person
Sahil Mahajan and Mandeep Bhamra are mutual person
Sahil Mahajan is a mutual person
Sahil Mahajan is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Salutem Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Salutem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Salutem Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Salutem Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Salutem Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jammu.
Mandeep Singh Bhamra was appointed as a Director was appointed as a Director on 17 Jul 2021 & has been associated with this company since 3 years 7 months .
Sahil Mahajan was appointed as a Director was appointed as a Director on 13 Oct 2016 & has been associated with this company since 8 years 4 months .
Salutem Pharmaceuticals Private Limited was registered on 13 Oct 2016 with Roc Jammu & aged 8 years 4 months as per MCA records.
Salutem Pharmaceuticals Private Limited was incorporated on 13 Oct 2016.
The authorized share capital of Salutem Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Salutem Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Salutem Pharmaceuticals Private Limited is Hall No. 211 B-1 2Nd Floor North Block, Bahu Plaza Kashmir India, Jammu, Jammu & Kashmir, 180012.
The corporate identification number (CIN) of Salutem Pharmaceuticals Private Limited is U24290JK2016PTC009772 and the company number is 009772 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2020, the revenue trend for Salutem Pharmaceuticals Private Limited has fallen by -8.97%.
The financial reports for the fiscal year 2020 indicates that The net worth of Salutem Pharmaceuticals Private Limited has experienced an upsurge of 16409.67%.
The most recent Balance Sheet for Salutem Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
AK